Hepatocellular adenoma future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Hepatocellular adenoma future or investigational therapies | ==Hepatocellular adenoma future or investigational therapies== | ||
==References== | ==References== |
Revision as of 13:58, 15 October 2015
Hepatocellular adenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatocellular adenoma future or investigational therapies On the Web |
American Roentgen Ray Society Images of Hepatocellular adenoma future or investigational therapies |
FDA on Hepatocellular adenoma future or investigational therapies |
CDC on Hepatocellular adenoma future or investigational therapies |
Hepatocellular adenoma future or investigational therapies in the news |
Blogs on Hepatocellular adenoma future or investigational therapies |
Risk calculators and risk factors for Hepatocellular adenoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]